Plinio Mark D. 4
4 · Evelo Biosciences, Inc. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
Plinio Mark D.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-14+250,000→ 250,000 totalExercise: $16.34Exp: 2031-06-14→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of underlying shares will vest on 1st anniversary of employment commencement date (i.e., June 14, 2022), and remaining 75% of underlying shares will vest in 36 substantially equal monthly installments thereafter